Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CRON
CRON logo

CRON Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
2.740
Open
2.720
VWAP
2.70
Vol
944.65K
Mkt Cap
1.02B
Low
2.675
Amount
2.55M
EV/EBITDA(TTM)
--
Total Shares
379.05M
EV
225.74M
EV/OCF(TTM)
8.73
P/S(TTM)
7.05
Cronos Group Inc. is a global cannabinoid company engaged in building disruptive intellectual property by advancing cannabis research, technology and product development. The Company’s diverse international brand portfolio includes Spinach, PEACE NATURALS and Lord Jones. Spinach is a mainstream adult-use cannabis brand with a portfolio that includes cannabinoid products in a wide range of formats, including dried flower, pre-rolls, vaporizers, edibles and tinctures. Lord Jones is a premium adult-use cannabis brand. The Lord Jones brand portfolio includes cannabis products in the pre-roll, vaporizer and edible categories. Lord Jones Ice Water Hash Fusions pre-rolls feature flower and terpene-rich ice water hash and are fitted with a branded ceramic tip. PEACE NATURALS is a global medical brand engaged in producing cannabis products. The Company distributes products under the PEACE NATURALS brand for the Canadian market and the Israeli, German, and United Kingdom medical markets.
Show More

Events Timeline

(ET)
2026-03-19
11:20:00
Representative Proposes Bill to Protect Legal Cannabis Businesses
select
link
2026-03-17 (ET)
2026-03-17
08:50:00
Significant Increases in Borrow Rates Among Liquid Option Names
select
2026-03-11 (ET)
2026-03-11
08:50:00
Significant Borrow Rate Increases Among Liquid Option Names
select
2026-02-26 (ET)
2026-02-26
07:50:00
Cronos Reports FY25 Net Revenue of $146.6M
select
2026-02-17 (ET)
2026-02-17
07:40:00
Cronos Group Launches New Spinach PUFFERZ Vape
select
2025-12-26 (ET)
2025-12-26
13:40:00
Trump Reaches Agreements with Pharma Companies to Lower Drug Prices
select
2025-12-24 (ET)
2025-12-24
09:50:00
Trump Delays New Tariffs on Chinese Chips for 18 Months
select

News

NASDAQ.COM
2.0
04-04NASDAQ.COM
Altria Group's High-Yield Dividend and Cannabis Investment
  • High-Yield Dividend: Altria Group offers a dividend yield exceeding 6%, providing investors with a steady cash flow, although its reliance on traditional cigarette sales remains high at 87%, indicating challenges in its transformation process.
  • Cannabis Investment Status: Altria invested approximately $1.8 billion in Canadian cannabis company Cronos, holding about 41% of its shares, yet this investment is currently valued at only $429 million, reflecting market caution towards the cannabis industry.
  • Revenue Trends: While Altria's annual revenue consistently exceeds $20 billion, its net revenue after excise taxes has declined annually since 2021, dropping from $21.1 billion to $20.1 billion, highlighting the long-term decline in the traditional cigarette market.
  • Future Strategy: Altria launched its
Fool
7.5
04-04Fool
Altria: A High-Yield Investment in Tobacco Amid Cannabis Interest
  • Strong Profitability: Altria Group generates over $20 billion in annual revenue, maintaining a high net margin of 75.86% despite the long-term decline in cigarette consumption, showcasing robust financial resilience in a competitive market.
  • Dividend King Status: With a 56-year streak of increasing dividends and a current yield of 6.39%, Altria remains a favorite among investors, particularly those seeking high-yield opportunities, further solidifying its market position.
  • Strategic Transformation: The company has launched its 'Moving Beyond Smoking' strategy, aiming to double revenue from next-generation tobacco products to $5 billion by 2028; despite regulatory challenges and competitive pressures, this transformation indicates a forward-looking approach to future markets.
  • Investment in Cannabis Market: Altria invested approximately $1.8 billion in Canadian cannabis company Cronos in 2019, holding a 41% stake; although its current value is only $429 million, the potential for significant returns increases as marijuana legalization progresses.
Fool
9.5
03-31Fool
Altria Faces Challenges in Tobacco Market
  • Stock Performance Review: While Altria has historically achieved an annual return of 20%, its performance over the past decade has been lackluster due to declining smoking rates in the U.S., highlighting the vulnerability of its core business.
  • Diversification Failures: Altria's investments in Cronos Group and Juul Labs have resulted in billions in losses, and its recent acquisition of NJOY faced a ban from the U.S. International Trade Commission due to patent infringement, exacerbating financial pressures.
  • New Product Sales Growth: Despite the decline in its core business, Altria's On! oral nicotine pouches saw an 11% increase in sales to 177.8 million cans over the past year, but a drop in market share indicates competitive pressures, particularly from Philip Morris's Zyn.
  • Future Earnings Outlook: Altria projects earnings per share growth of 2.5% to 5.5%, reaching $5.56 to $5.72 in 2026, and with a 6.3% dividend yield, it still presents some investment appeal despite the risks associated with its declining core business.
NASDAQ.COM
7.5
03-31NASDAQ.COM
Altria's Diversification Efforts Falter
  • Core Business Decline: Altria has managed profit growth by raising cigarette prices, yet its 2025 revenue after excise taxes fell 1.5% to $20.1 billion, indicating a persistent decline in its core business and significant risks for future growth.
  • New Product Market Competition: Altria's On! oral nicotine pouches saw an 11% shipment increase to 177.8 million cans over the past year, but a decline in market share in Q4 due to Zyn's promotions suggests limited market acceptance for new products.
  • Shareholder Returns and Risks: Despite a roughly 50% stock price increase over the past two years, Altria's 2026 earnings per share target of $5.56 to $5.72, combined with a 6.3% dividend yield, highlights the challenges and uncertainties the company faces during its transition.
  • Uncertain Industry Outlook: With smoking rates among young Americans continuing to decline, Altria's cigarette sales are almost certain to keep falling, and if the company cannot replace lost profits with new products, its long-term stock price will face downward pressure.
seekingalpha
9.5
02-26seekingalpha
Cronos Group Reports Record Growth in 2025 Earnings Call
  • Significant Revenue Growth: Cronos Group reported a consolidated net revenue of $44.5 million for Q4 2025, reflecting a 47% year-over-year increase driven by strong cannabis flower sales in Israel and Canada, underscoring the continued strength of its core business.
  • Market Leadership Reinforced: The Spinach brand emerged as the second-largest vape brand in Canada and achieved the top market share in vape cartridges, further solidifying the company's leadership position in the rapidly growing consumer goods market.
  • Strategic Acquisition Plans: The company announced a definitive agreement to acquire CanAdelaar, the largest operator in the Netherlands' legal adult-use cannabis program, for €57.5 million (approximately $67.5 million), with closing expected in H1 2026, which will provide robust support for the company's expansion into the European market.
  • Strong Financial Position: Cronos Group maintains the strongest balance sheet in the industry with no debt and $832 million in cash and short-term investments, demonstrating the company's financial flexibility for future expansions and acquisitions.
seekingalpha
9.5
02-26seekingalpha
Cronos Reports Q4 Revenue Beat Despite Net Loss
  • Significant Revenue Growth: Cronos reported $44.5 million in revenue for Q4 2025, reflecting approximately 47% year-over-year growth, exceeding market expectations by $5.8 million, primarily driven by improved flower sales in multiple countries, including Israel.
  • Gross Profit Increase: The company's gross profit rose nearly 50% year-over-year to $16.2 million, indicating enhanced sales volumes and average selling prices, although overall performance was impacted by foreign currency transaction losses.
  • Net Loss Reported: Despite revenue growth, Cronos swung to a net loss of $0.5 million from a net income of $43.9 million in the prior-year period, highlighting the significant impact of foreign exchange losses on the company's financials.
  • Annual Financial Overview: For the full year, Cronos posted a net loss of $9.4 million on $146.6 million in revenue, indicating approximately 25% year-over-year growth, while cash and cash equivalents fell about 8% year-over-year to $791.8 million, reflecting financial pressures amid market expansion efforts.
Wall Street analysts forecast CRON stock price to rise
2 Analyst Rating
Wall Street analysts forecast CRON stock price to rise
1 Buy
1 Hold
0 Sell
Moderate Buy
Current: 0.000
sliders
Low
2.30
Averages
2.72
High
3.14
Current: 0.000
sliders
Low
2.30
Averages
2.72
High
3.14
TD Securities
NULL -> Buy
initiated
$4.50
AI Analysis
2026-02-24
Reason
TD Securities
Price Target
$4.50
AI Analysis
2026-02-24
initiated
NULL -> Buy
Reason
TD Securities initiated coverage of Cronos Group with a Buy rating and C$4.50 price target. Cronos, which has "some of the most iconic Canadian cannabis brands on the market, is well-positioned to improve profitability as it scales the top-line with a lean operating cost base and leading cultivation practices, the analyst tells investors.
Canaccord
Kenric Tyghe
Buy
initiated
$4.25
2026-01-27
Reason
Canaccord
Kenric Tyghe
Price Target
$4.25
2026-01-27
initiated
Buy
Reason
Canaccord analyst Kenric Tyghe initiated coverage of Cronos Group with a Buy rating and C$4.25 price target. While Canada and Israel are the company's two largest markets today, the firm believes that its recent acquisition of CanAdelaar and the expansion of Cronos Growing Company are "the leading edge of transformational change at the company," the analyst tells investors in a note starting coverage of the the Canadian cannabis group.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CRON
Unlock Now

Valuation Metrics

The current forward P/E ratio for Cronos Group Inc (CRON.O) is 31.85, compared to its 5-year average forward P/E of 378.02. For a more detailed relative valuation and DCF analysis to assess Cronos Group Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
378.02
Current PE
31.85
Overvalued PE
1591.13
Undervalued PE
-835.08

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-1.23
Current EV/EBITDA
-7.29
Overvalued EV/EBITDA
9.04
Undervalued EV/EBITDA
-11.49

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
10.01
Current PS
3.16
Overvalued PS
17.37
Undervalued PS
2.65

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

Give me the top 5 cannabis companies
Intellectia · 4 candidates
Market Cap: >= 500.00MRevenue Ttm: >= 100.00MRegion: USThemes: The Cannabis IndustryList Exchange: XNYS, XNAS, XASEIs Optionable: TrueMonthly Average Dollar Volume: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
SMG logo
SMG
Scotts Miracle-Gro Co
3.52B
IIPR logo
IIPR
Innovative Industrial Properties Inc
1.43B
CRON logo
CRON
Cronos Group Inc
947.63M
TLRY logo
TLRY
Tilray Brands Inc
736.32M
Should I Buy cannabis stocks?
Intellectia · 9 candidates
Market Cap: >= 50.00MThemes: The Cannabis IndustryList Exchange: XNYS, XNASMonthly Average Dollar Volume: >= 100,000
Ticker
Name
Market Cap$
top bottom
SMG logo
SMG
Scotts Miracle-Gro Co
4.06B
IIPR logo
IIPR
Innovative Industrial Properties Inc
1.29B
CRON logo
CRON
Cronos Group Inc
1.01B
TLRY logo
TLRY
Tilray Brands Inc
874.97M
CGC logo
CGC
Canopy Growth Corp
440.50M
SNDL logo
SNDL
SNDL Inc
386.25M
what cannabis stocks would you buy?
Intellectia · 4 candidates
Market Cap: >= 200.00MPrice: >= $1.00Themes: The Cannabis IndustryQuarter Revenue Yoy Growth: >= 0.0%Monthly Average Dollar Volume: >= 300,000
Ticker
Name
Market Cap$
top bottom
CRON logo
CRON
Cronos Group Inc
1.01B
TLRY logo
TLRY
Tilray Brands Inc
874.97M
SNDL logo
SNDL
SNDL Inc
386.25M
ACB logo
ACB
Aurora Cannabis Inc
204.15M
cannabis
Intellectia · 8 candidates
Market Cap: >= 200.00MPrice: >= $1.00Themes: The Cannabis IndustryIs Optionable: TrueMonthly Average Dollar Volume: >= 200,000
Ticker
Name
Market Cap$
top bottom
SMG logo
SMG
Scotts Miracle-Gro Co
4.06B
IIPR logo
IIPR
Innovative Industrial Properties Inc
1.29B
CRON logo
CRON
Cronos Group Inc
1.01B
TLRY logo
TLRY
Tilray Brands Inc
874.97M
CGC logo
CGC
Canopy Growth Corp
440.50M
SNDL logo
SNDL
SNDL Inc
386.25M
best penny stocks to buy
Intellectia · 45 candidates
Market Cap: 50.00M - 1000.00MRegion: USPrice: $0.20 - $5.00Eps Ttm: >= 0Beta: ModerateRisk, HighRiskList Exchange: XNYS, XNAS, XASEMonthly Average Dollar Volume: >= 500,000
Ticker
Name
Market Cap$
top bottom
HIVE logo
HIVE
HIVE Digital Technologies Ltd
695.26M
REI logo
REI
Ring Energy Inc
246.60M
GAU logo
GAU
Galiano Gold Inc
691.04M
LDI logo
LDI
loanDepot Inc
726.45M
ITRG logo
ITRG
Integra Resources Corp
671.92M
MVST logo
MVST
Microvast Holdings Inc
859.84M
marijuana stocks
Intellectia · 8 candidates
Market Cap: >= 200.00MRegion: US, CanadaPrice: >= $1.00Themes: The Cannabis IndustryList Exchange: XNYS, XNAS, XASEIs Optionable: TrueMonthly Average Dollar Volume: >= 300,000
Ticker
Name
Market Cap$
top bottom
SMG logo
SMG
Scotts Miracle-Gro Co
3.70B
IIPR logo
IIPR
Innovative Industrial Properties Inc
1.41B
TLRY logo
TLRY
Tilray Brands Inc
1.01B
CRON logo
CRON
Cronos Group Inc
999.35M
CGC logo
CGC
Canopy Growth Corp
460.70M
SNDL logo
SNDL
SNDL Inc
406.85M
which. cannabisindustry should I invest in
Intellectia · 2 candidates
Market Cap: >= 500.00MThemes: The Cannabis IndustryWeekly Average Turnover: >= 1,000,000Annual Revenue Yoy Growth: >= 0.0%
Ticker
Name
Market Cap$
top bottom
TLRY logo
TLRY
Tilray Brands Inc
1.01B
CRON logo
CRON
Cronos Group Inc
999.35M
whats the best penny stocks to invest into
Intellectia · 25 candidates
Market Cap: <= 1000.00MPrice: <= $5.00Eps Ttm: >= 0Weekly Average Turnover: >= 1,000,000Annual Revenue Yoy Growth: >= 10.0%
Ticker
Name
Market Cap$
top bottom
CRON logo
CRON
Cronos Group Inc
999.35M
GOGO logo
GOGO
Gogo Inc
642.50M
TALK logo
TALK
Talkspace Inc
632.81M
DDL logo
DDL
Dingdong (Cayman) Ltd
602.62M
NPWR logo
NPWR
NET Power Inc
575.35M
VTEX logo
VTEX
VTEX
573.92M
Cannibus stocks
Intellectia · 4 candidates
Market Cap: >= 500.00MThemes: The Cannabis IndustryBeta: ModerateRisk, HighRiskWeekly Average Turnover: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
SMG logo
SMG
Scotts Miracle-Gro Co
3.70B
IIPR logo
IIPR
Innovative Industrial Properties Inc
1.41B
TLRY logo
TLRY
Tilray Brands Inc
1.01B
CRON logo
CRON
Cronos Group Inc
999.35M
stocks under $5 today worth buying
Intellectia · 41 candidates
Market Cap: >= 300.00MPrice: <= $5.00Beta: ModerateRiskWeekly Average Turnover: >= 1,000,000Rsi 14: 30 - 70
Ticker
Name
Market Cap$
top bottom
WIT logo
WIT
Wipro Ltd
27.24B
LPL logo
LPL
LG Display Co Ltd
4.32B
CSAN logo
CSAN
Cosan SA
4.02B
COTY logo
COTY
Coty Inc
2.85B
RLX logo
RLX
RLX Technology Inc
2.75B
BTE logo
BTE
Baytex Energy Corp
2.64B

Whales Holding CRON

A
Altria Group, Inc.
Holding
CRON
+9.88%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Cronos Group Inc (CRON) stock price today?

The current price of CRON is 2.69 USD — it has increased 0.37

What is Cronos Group Inc (CRON)'s business?

Cronos Group Inc. is a global cannabinoid company engaged in building disruptive intellectual property by advancing cannabis research, technology and product development. The Company’s diverse international brand portfolio includes Spinach, PEACE NATURALS and Lord Jones. Spinach is a mainstream adult-use cannabis brand with a portfolio that includes cannabinoid products in a wide range of formats, including dried flower, pre-rolls, vaporizers, edibles and tinctures. Lord Jones is a premium adult-use cannabis brand. The Lord Jones brand portfolio includes cannabis products in the pre-roll, vaporizer and edible categories. Lord Jones Ice Water Hash Fusions pre-rolls feature flower and terpene-rich ice water hash and are fitted with a branded ceramic tip. PEACE NATURALS is a global medical brand engaged in producing cannabis products. The Company distributes products under the PEACE NATURALS brand for the Canadian market and the Israeli, German, and United Kingdom medical markets.

What is the price predicton of CRON Stock?

Wall Street analysts forecast CRON stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CRON is2.72 USD with a low forecast of 2.30 USD and a high forecast of 3.14 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Cronos Group Inc (CRON)'s revenue for the last quarter?

Cronos Group Inc revenue for the last quarter amounts to 44.53M USD, increased 46.96

What is Cronos Group Inc (CRON)'s earnings per share (EPS) for the last quarter?

Cronos Group Inc. EPS for the last quarter amounts to -0.00 USD, decreased -100.00

How many employees does Cronos Group Inc (CRON). have?

Cronos Group Inc (CRON) has 356 emplpoyees as of April 20 2026.

What is Cronos Group Inc (CRON) market cap?

Today CRON has the market capitalization of 1.02B USD.